Animal Gut Health

Short Summary

Developed and patented a unique ingredient called Enzyme Rich Malt Extract (ERME). ERME, when used as a feed additive or supplement improves animal digestive health by creating more favourable conditions for the animal’s own microbiome to flourish


Investment Raised
Previous Rounds £225,000
Stage Achieving Sales
Investor Role Monthly Involvement


  • TEAM Experienced leadership, specialists in taking companies to exit
  • SIMON ROWLANDS Rowlands Racing & Research Ltd “A game changer"
  • STUART WILLIAMS Professional Racehorse Trainer “record breaking season"
  • Cumani “Vital to our yard routine, EquiNectar keeps horses consistent"
  • 3x patent families pending
Please note: The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Investors should carry out their own due diligence and take professional advice where necessary.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
20% raised

Miigen Seed Fund Raise

location_on Scotland, United Kingdom

Miigen is a Private Social Platform which is enhancing the quality of Later Life Living and the mental wellbeing of our aging population. Miigen will be the platform of choice for advice, products and services on later life living.

£ 500,000


£ 10,000

Min per Investor

Global Pro
16% raised

The AI Speech Therapist

location_on London, United Kingdom

Our vision is to build the most accessible and effective AI speech and language therapy that has the potential to transform the lives of 10% of the population.

£ 250,000


£ 10,000

Min per Investor

60% raised

Ampersand Health

location_on London, United Kingdom

Ampersand Health is a digital medicine platform improving treatment of inflammatory condition. Revenue generating, they have 14,000 patients signed-up and integrations with 15 hospitals. The Founder has 2 previous exits including 1 in digital health.

£ 1,000,000


£ 25,000

Min per Investor

load one similar proposal